During pregnancy, women are checked for anaemia twice – once at the initial booking visit (usually around 8-10 weeks) and again at 28 weeks. The National Institute for Health and Care Excellence (NICE) has set specific cut-off levels to determine if a pregnant woman requires oral iron therapy. These levels are less than 110 g/L in the first trimester, less than 105 g/L in the second and third trimesters, and less than 100 g/L postpartum.

If a woman’s iron levels fall below these cut-offs, she will be prescribed oral ferrous sulfate or ferrous fumarate. It is important to continue this treatment for at least three months after the iron deficiency has been corrected to allow the body to replenish its iron stores. By following these guidelines, healthcare professionals can help ensure that pregnant women receive the appropriate care to prevent and manage anaemia during pregnancy.

All women with PPROM should receive a 10-day course of erythromycin. This is the recommended treatment for this condition. Piperacillin and tazobactam (tazocin) is not appropriate due to the patient’s penicillin allergy. Nitrofurantoin is used for urinary tract infections, while vancomycin is typically used for anaerobic GI infections.

Preterm prelabour rupture of the membranes (PPROM) is a condition that occurs in approximately 2% of pregnancies, but it is responsible for around 40% of preterm deliveries. This condition can lead to various complications, including prematurity, infection, and pulmonary hypoplasia in the fetus, as well as chorioamnionitis in the mother. To confirm PPROM, a sterile speculum examination should be performed to check for pooling of amniotic fluid in the posterior vaginal vault. However, digital examination should be avoided due to the risk of infection. If pooling of fluid is not observed, testing the fluid for placental alpha microglobulin-1 protein (PAMG-1) or insulin-like growth factor binding protein-1 is recommended. Ultrasound may also be useful to show oligohydramnios.

The management of PPROM involves admission and regular observations to ensure that chorioamnionitis is not developing. Oral erythromycin should be given for ten days, and antenatal corticosteroids should be administered to reduce the risk of respiratory distress syndrome. Delivery should be considered at 34 weeks of gestation, but there is a trade-off between an increased risk of maternal chorioamnionitis and a decreased risk of respiratory distress syndrome as the pregnancy progresses. PPROM is a serious condition that requires prompt diagnosis and management to minimize the risk of complications for both the mother and the fetus.

It is recommended that pregnant women with a family history of diabetes undergo an oral glucose tolerance test (OGTT) for gestational diabetes between 24 and 28 weeks of pregnancy.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

The McRobert’s manoeuvre is an efficient and uncomplicated method to address shoulder dystocia. By enhancing the flexibility of the sacroiliac joints, it facilitates pelvic rotation and the subsequent release of the fetal shoulder. It is crucial to immediately seek assistance upon identifying shoulder dystocia.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the fetus. Risk factors for shoulder dystocia include fetal macrosomia, high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior help immediately. The McRoberts’ maneuver is often performed, which involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant maternal morbidity. Oxytocin administration is not indicated for shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury and neonatal death for the fetus. It is important to manage shoulder dystocia promptly and appropriately to minimize the risk of these complications.

If pre-eclampsia is suspected in a woman, NICE recommends arranging emergency secondary care assessment. This is because pre-eclampsia can be asymptomatic and potentially life-threatening. In this case, the patient has high blood pressure (>=140/90 mmHg) and proteinuria (>= +1), which are features of pre-eclampsia. While a growth scan may be necessary as part of her overall management, it is not the priority at this time. Home BP monitoring is also not indicated now, as she needs further assessment first. Repeating the assessment in 24 hours is not appropriate, as emergency secondary care assessment is necessary. While labetalol may be used to manage her blood pressure, it should not be initiated before obstetric specialist investigation and input.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, and age over 40. Aspirin may be recommended for women with high or moderate risk factors. Treatment involves emergency assessment, admission for observation, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

The first step in managing chickenpox exposure during pregnancy is to confirm the patient’s immunity by checking her varicella-zoster antibodies. If the woman is unsure about her past exposure to chickenpox, this test will determine if she has antibodies to the virus. If the test confirms her immunity, no further action is necessary. Administering the varicella-zoster vaccine or IV immunoglobulin is not appropriate in this situation. Neglecting to check the patient’s immunity status can put her and her unborn child at risk.

Chickenpox exposure in pregnancy can pose risks to both the mother and fetus, including fetal varicella syndrome. Post-exposure prophylaxis (PEP) with varicella-zoster immunoglobulin (VZIG) or antivirals should be given to non-immune pregnant women, with timing dependent on gestational age. If a pregnant woman develops chickenpox, specialist advice should be sought and oral acyclovir may be given if she is ≥ 20 weeks and presents within 24 hours of onset of the rash.

Fetal fibronectin (fFN) is a protein that is released from the gestational sac and is associated with early labor if levels are high. However, a positive result does not guarantee premature labor. Obstetric teams can use this information to prepare for the possibility of premature labor by informing neonatal intensive care and administering steroids to aid in neonatal lung maturity. In this case, the patient is at high risk for premature labor and experiencing tightenings, so further monitoring is necessary before discharge.

Antibiotics may be necessary if the patient had spontaneously ruptured her membranes, but in this case, a history of watery discharge without fluid seen on speculum examination and a closed os is not enough to initiate antibiotic therapy. However, swabs and urine cultures should be obtained to screen for infection and treat as appropriate since infection can be a factor in premature labor.

Administering steroids can cause hyperglycemia in diabetics, so blood glucose measurements should be closely monitored. Hyperglycemia in the mother can have adverse effects on the fetus, so hourly blood glucose measurements should be taken, and additional insulin given as needed. If blood glucose levels are difficult to control, a sliding scale should be initiated according to local protocol.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

Peripartum Complications: Sheehan’s Syndrome, Eclampsia, and Other Causes of Headache and Visual Disturbances

Peripartum complications can present with a variety of symptoms, including headache and visual disturbances. Sheehan’s syndrome is a condition that results from pituitary infarction due to haemorrhagic shock during labour and the peripartum period. It typically affects the anterior pituitary, leading to hormonal deficiencies that may present acutely or more indolently. Hormone replacement is the mainstay of treatment.

Eclampsia is another peripartum complication that can cause high blood pressure and seizures, sometimes leading to loss of consciousness. It requires urgent medical attention.

Other causes of headache and visual disturbances in the peripartum period include subarachnoid haemorrhage, which may present with sudden onset headache and visual disturbances, and extradural haemorrhage, which is typically found in trauma adjacent to fractures of the temporal bone. Occipital haemorrhagic infarction can also cause these symptoms, but a visual field defect is more suggestive of Sheehan’s syndrome.

It is important for healthcare providers to be aware of these potential complications and to promptly evaluate and manage them to ensure the best possible outcomes for both mother and baby.

When caring for a newborn, it can be difficult for a mother to remember to take the progesterone-only pill at the same time every day. Long-acting reversible contraception options, such as the progesterone implant, copper coil, and levonorgestrel-releasing intrauterine system, are recommended. The progesterone implant is safe for breastfeeding women and can last for up to three years. The levonorgestrel-releasing intrauterine system can be used after four weeks postpartum, but insertion should be avoided in the first few weeks due to the risk of perforation. The combined oral contraceptive pill is not recommended until six weeks postpartum due to the increased risk of thromboembolism. The copper coil can be considered after four weeks postpartum, and the progesterone-only pill can be used from the first day postpartum, but it must be taken at the same time every day. A long-acting progesterone contraceptive device may be more suitable for a mother who finds it difficult to take medication at the same time every day.

If high blood pressure occurs after 20 weeks gestation and there is no proteinuria, it is considered gestational hypertension. However, if high blood pressure is present before 20 weeks, it is likely pre-existing hypertension.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

Management of Postpartum Hemorrhage: Conservative and Pharmacological Methods

Postpartum hemorrhage is a common complication of childbirth and can be life-threatening if not managed promptly. The causes of postpartum hemorrhage fall under four categories, known as the 4Ts: tissue problems, tone problems, trauma, and thrombin. In cases of uterine atony, which is the most common cause of postpartum hemorrhage, conservative and pharmacological methods should be employed first.

The initial assessment should include securing two large-bore cannulae, sending blood for urgent full blood count, group and save, clotting and crossmatch of four units of blood, and commencing intravenous fluids. Uterine massage of the fundus, as well as an oxytocin infusion, should be the first step in management. If pharmacological methods fail to arrest the bleeding, then an intrauterine balloon can be employed as second line. If this still fails, the patient should be transferred to theatre for exploration and hysterectomy if necessary.

Ergometrine is contraindicated in women with hypertension, and therefore, should not be used in patients with a raised blood pressure. Hysterectomy is a last resort in women with massive postpartum hemorrhage where mechanical and pharmacological methods have failed to stop the bleeding and the patient is haemodynamically compromised. Intrauterine balloon tamponade is an effective mechanical method to stop postpartum hemorrhage in cases where other methods have failed.

It is important to ensure that blood is available if necessary, but transfusion should not be treated lightly due to the potential for severe complications. An up-to-date hemoglobin level should be obtained, and the patient should be fluid-resuscitated and monitored before any decision for transfusion. Overall, prompt and appropriate management of postpartum hemorrhage is crucial for ensuring positive maternal outcomes.

Understanding Ectopic Pregnancy

Ectopic pregnancy occurs when a fertilized egg implants outside the uterus. This condition is characterized by lower abdominal pain and vaginal bleeding, typically occurring 6-8 weeks after the start of the last period. The pain is usually constant and may be felt on one side of the abdomen due to tubal spasm. Vaginal bleeding is usually less than a normal period and may be dark brown in color. Other symptoms may include shoulder tip pain, pain on defecation/urination, dizziness, fainting, or syncope. Breast tenderness may also be reported.

During examination, abdominal tenderness and cervical excitation may be observed. However, it is not recommended to examine for an adnexal mass due to the risk of rupturing the pregnancy. Instead, a pelvic examination to check for cervical excitation is recommended. In cases of pregnancy of unknown location, serum bHCG levels >1,500 may indicate an ectopic pregnancy. It is important to seek medical attention immediately if ectopic pregnancy is suspected as it can be life-threatening.

Based on the presented symptoms, the most probable diagnosis is acute fatty liver of pregnancy. This is supported by the presence of jaundice, mild fever, elevated liver function tests, increased white blood cell count, coagulopathy, and steatosis on imaging. Acute fatty liver of pregnancy typically presents with non-specific symptoms such as fatigue, malaise, and nausea, whereas cholestasis of pregnancy is characterized by severe itching. The absence of abnormalities in hemoglobin, platelet count, and viral screening makes the diagnosis of HELLP syndrome or viral hepatitis unlikely. Additionally, pre-eclampsia is characterized by hypertension and proteinuria. It is important to note that placental ALP can cause an increase in serum ALP levels during pregnancy.

Liver Complications During Pregnancy

During pregnancy, there are several liver complications that may arise. One of the most common is intrahepatic cholestasis of pregnancy, which occurs in about 1% of pregnancies and is typically seen in the third trimester. Symptoms include intense itching, especially in the palms and soles, as well as elevated bilirubin levels. Treatment involves the use of ursodeoxycholic acid for relief and weekly liver function tests. Women with this condition are usually induced at 37 weeks to prevent stillbirth, although maternal morbidity is not typically increased.

Another rare complication is acute fatty liver of pregnancy, which may occur in the third trimester or immediately after delivery. Symptoms include abdominal pain, nausea and vomiting, headache, jaundice, and hypoglycemia. Severe cases may result in pre-eclampsia. ALT levels are typically elevated, and support care is the primary management until delivery can be performed once the patient is stabilized.

Finally, conditions such as Gilbert’s and Dubin-Johnson syndrome may be exacerbated during pregnancy. Additionally, HELLP syndrome, which stands for haemolysis, elevated liver enzymes, and low platelets, is a serious complication that can occur in the third trimester and requires immediate medical attention. Overall, it is important for pregnant women to be aware of these potential liver complications and to seek medical attention if any symptoms arise.

If lochia continues for more than 6 weeks, an ultrasound should be performed.

During the puerperium, which is the period of around 6 weeks after childbirth when the woman’s reproductive organs return to their normal state, lochia is the discharge of blood, mucous, and uterine tissue that occurs. It is expected to stop after 4-6 weeks. However, if it persists beyond this time, an ultrasound is necessary to investigate the possibility of retained products of conception.

Lochia refers to the discharge that is released from the vagina after childbirth. This discharge is composed of blood, mucous, and uterine tissue. It is a normal occurrence that can last for up to six weeks following delivery. During this time, the body is working to heal and recover from the physical changes that occurred during pregnancy and childbirth. It is important for new mothers to monitor their lochia and report any unusual changes or symptoms to their healthcare provider.

To treat postpartum haemorrhage caused by uterine atony, medical options include oxytocin, ergometrine, carboprost, and misoprostol.

The leading cause of primary postpartum haemorrhage is uterine atony. The RCOG has issued guidelines (Green-top Guideline No.52) for managing primary PPH due to uterine atony. The first-line treatment recommended is 5U of IV Syntocinon (oxytocin), followed by 0.5 mg of ergometrine.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage (PPH) is a condition where a woman experiences blood loss of more than 500 ml after giving birth vaginally. It can be classified as primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia.

In managing PPH, it is important to involve senior staff immediately and follow the ABC approach. This includes two peripheral cannulae, lying the woman flat, blood tests, and commencing a warmed crystalloid infusion. Mechanical interventions such as rubbing up the fundus and catheterisation are also done. Medical interventions include IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options such as intrauterine balloon tamponade, B-Lynch suture, ligation of uterine arteries, and hysterectomy may be considered if medical options fail to control the bleeding.

Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to understand the causes and risk factors of PPH to prevent and manage this life-threatening emergency effectively.

The intrauterine device or intrauterine system can be inserted within 48 hours of childbirth or after a minimum of 4 weeks. However, it is important to note that insertion between 48 hours and 4 weeks after delivery should be avoided due to the increased risk of expulsion and lack of data on uterine perforation with newer models. In addition to general contraindications, contraindications to postpartum insertion within 48 hours include peripartum chorioamnionitis, endometritis, puerperal sepsis, or post-partum haemorrhage. Waiting a minimum of 6 weeks or 2 months after delivery is not necessary. If waiting the recommended minimum of 4 weeks, the progesterone-only pill may be used as an interim measure to reduce the risk of pregnancy.

After giving birth, women need to use contraception after 21 days. The progesterone-only pill (POP) can be started at any time postpartum, according to the FSRH. Additional contraception should be used for the first two days after day 21. A small amount of progesterone enters breast milk, but it is not harmful to the infant. On the other hand, the combined oral contraceptive pill (COCP) is absolutely contraindicated (UKMEC 4) if breastfeeding is less than six weeks post-partum. If breastfeeding is between six weeks and six months postpartum, it is a UKMEC 2. The COCP may reduce breast milk production in lactating mothers. It should not be used in the first 21 days due to the increased venous thromboembolism risk post-partum. After day 21, additional contraception should be used for the first seven days. The intrauterine device or intrauterine system can be inserted within 48 hours of childbirth or after four weeks.

The lactational amenorrhoea method (LAM) is 98% effective if the woman is fully breastfeeding (no supplementary feeds), amenorrhoeic, and less than six months post-partum. It is important to note that an inter-pregnancy interval of less than 12 months between childbirth and conceiving again is associated with an increased risk of preterm birth, low birth weight, and small for gestational age babies.

Performing any form of female genital cutting/modification for non-medical reasons, including reinfibulation of a woman with type 3 FGM after vaginal delivery, is illegal according to the Female Genital Mutilation Act 2003. It is strictly prohibited to carry out such procedures under any circumstances. However, discussing the topic is not illegal.

Understanding Female Genital Mutilation

Female genital mutilation (FGM) is a term used to describe any procedure that involves the partial or complete removal of the external female genitalia or any other injury to the female genital organs for non-medical reasons. The World Health Organization (WHO) has classified FGM into four types. Type 1 involves the partial or total removal of the clitoris and/or the prepuce, while type 2 involves the partial or total removal of the clitoris and the labia minora, with or without excision of the labia majora. Type 3 involves the narrowing of the vaginal orifice with the creation of a covering seal by cutting and appositioning the labia minora and/or the labia majora, with or without excision of the clitoris. Finally, type 4 includes all other harmful procedures to the female genitalia for non-medical purposes, such as pricking, piercing, incising, scraping, and cauterization. It is important to understand the different types of FGM to raise awareness and prevent this harmful practice.

Fetal Abnormalities: Causes and Characteristics

Polyhydramnios, oligohydramnios, macrosomia, fetal oedema, and microcephaly are all fetal abnormalities with distinct causes and characteristics. Polyhydramnios is an accumulation of amniotic fluid caused by impaired swallowing due to oesophageal atresia. Oligohydramnios, on the other hand, is a lack of amniotic fluid caused by various factors such as chromosomal abnormalities and renal agenesis. Macrosomia, or a large-for-gestational age baby, is commonly caused by gestational diabetes. Fetal oedema, also known as hydrops fetalis, is characterised by an excess of fluid in the fetus and can be caused by immunological or non-immunological factors. Finally, microcephaly is a congenital abnormality characterised by a small head circumference and can be caused by various factors such as chromosomal abnormalities and infections. Understanding the causes and characteristics of these fetal abnormalities is crucial for proper diagnosis and management.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

The appropriate course of action for a woman exhibiting symptoms of agitation and paranoid delusions after giving birth is to admit her to the hospital for urgent assessment. This is likely a case of postpartum psychosis, which is different from postnatal depression. Postpartum psychosis can include mania, depression, irritability, rapid mood changes, confusion, paranoia, delusions, and/or hallucinations. Prescribing medication to aid in sleep is not appropriate in this case, and reassurance that her low mood will improve with time is also not appropriate due to the risk to herself and her baby. Gradual titration of fluoxetine would not manage her acute symptoms and would not ensure the safety of her or her baby. Ideally, she should be hospitalized in a Mother & Baby Unit.

Understanding Postpartum Mental Health Problems

Postpartum mental health problems can range from mild ‘baby-blues’ to severe puerperal psychosis. To screen for depression, healthcare professionals may use the Edinburgh Postnatal Depression Scale, which is a 10-item questionnaire that indicates how the mother has felt over the previous week. A score of more than 13 indicates a ‘depressive illness of varying severity’, with sensitivity and specificity of more than 90%. The questionnaire also includes a question about self-harm.

‘Baby-blues’ is seen in around 60-70% of women and typically occurs 3-7 days following birth. It is more common in primips, and mothers are characteristically anxious, tearful, and irritable. Reassurance and support from healthcare professionals, particularly health visitors, play a key role in managing this condition. Most women with the baby blues will not require specific treatment other than reassurance.

Postnatal depression affects around 10% of women, with most cases starting within a month and typically peaking at 3 months. The features are similar to depression seen in other circumstances, and cognitive behavioural therapy may be beneficial. Certain SSRIs such as sertraline and paroxetine may be used if symptoms are severe. Although these medications are secreted in breast milk, they are not thought to be harmful to the infant.

Puerperal psychosis affects approximately 0.2% of women and requires admission to hospital, ideally in a Mother & Baby Unit. Onset usually occurs within the first 2-3 weeks following birth, and features include severe swings in mood (similar to bipolar disorder) and disordered perception (e.g. auditory hallucinations). There is around a 25-50% risk of recurrence following future pregnancies. Paroxetine is recommended by SIGN because of the low milk/plasma ratio, while fluoxetine is best avoided due to a long half-life.

It is recommended that HIV testing be included as a standard part of antenatal screening.

Antenatal Screening Policy

Antenatal screening is an important aspect of prenatal care that helps identify potential health risks for both the mother and the developing fetus. The National Screening Committee (NSC) has recommended a policy for antenatal screening that outlines the conditions for which all pregnant women should be offered screening and those for which screening should not be offered.

The NSC recommends that all pregnant women should be offered screening for anaemia, bacteriuria, blood group, Rhesus status, and anti-red cell antibodies, Down’s syndrome, fetal anomalies, hepatitis B, HIV, neural tube defects, risk factors for pre-eclampsia, syphilis, and other conditions depending on the woman’s medical history.

However, there are certain conditions for which screening should not be offered, such as gestational diabetes, gestational hypertension, and preterm labor. These conditions are typically managed through regular prenatal care and monitoring.

It is important for pregnant women to discuss their screening options with their healthcare provider to ensure that they receive appropriate care and support throughout their pregnancy. By following the NSC’s recommended policy for antenatal screening, healthcare providers can help identify potential health risks early on and provide appropriate interventions to ensure the best possible outcomes for both mother and baby.

Pregnant women with a BMI of ≥30 kg/m² should be given a high dose of 5mg folic acid to prevent neural tube defects (NTD) in the first trimester of pregnancy. This is in addition to patients with diabetes, sickle cell disease (SCD), thalassaemia trait, coeliac disease, on anti-epileptic medication, personal or family history of NTD, or who have previously given birth to a baby with an NTD. Folic acid should ideally be started before conception to further reduce the risk of NTD. However, a history of asthma, smoking, patient age, and Asian ethnicity are not indications for high-dose folic acid prescribing in pregnancy. Pregnant smokers should not be prescribed high-dose folic acid, although smoking during pregnancy is a risk factor for prematurity, low birth weight, and cleft lip/palate. There is currently no evidence to support high-dose folic acid prescribing for pregnant women with asthma or those at the extremes of maternal age. Additionally, all pregnant women should take vitamin D 10mcg (400 units) daily throughout their pregnancy, as recommended by NICE.

Folic Acid: Importance, Deficiency, and Prevention

Folic acid is a vital nutrient that is converted to tetrahydrofolate (THF) in the body. It is found in green, leafy vegetables and plays a crucial role in the transfer of 1-carbon units to essential substrates involved in the synthesis of DNA and RNA. However, certain factors such as phenytoin, methotrexate, pregnancy, and alcohol excess can cause a deficiency in folic acid. This deficiency can lead to macrocytic, megaloblastic anemia and neural tube defects.

To prevent neural tube defects during pregnancy, it is recommended that all women take 400mcg of folic acid until the 12th week of pregnancy. Women at higher risk of conceiving a child with a neural tube defect should take 5mg of folic acid from before conception until the 12th week of pregnancy. Women are considered higher risk if they or their partner has a neural tube defect, they have had a previous pregnancy affected by a neural tube defect, or they have a family history of a neural tube defect. Additionally, women with certain medical conditions such as coeliac disease, diabetes, or thalassaemia trait, or those taking antiepileptic drugs, or who are obese (BMI of 30 kg/m2 or more) are also considered higher risk.

In summary, folic acid is an essential nutrient that plays a crucial role in DNA and RNA synthesis. Deficiency in folic acid can lead to serious health consequences, including neural tube defects. However, taking folic acid supplements during pregnancy can prevent these defects and ensure a healthy pregnancy.

Twin-to-twin transfusion syndrome (TTTS) is a common complication that can occur in monochorionic twin pregnancies. This happens when the two fetuses share a single placenta, allowing blood to flow between them. However, in TTTS, one twin (the ‘donor’) receives less blood flow from the placenta than the other twin (the ‘recipient’) due to abnormalities in the placental blood vessels. This can cause the recipient to become overloaded with fluid, while the donor may become anemic. Additionally, differences in urine production can lead to one twin having too little amniotic fluid (oligohydramnios) and the other having too much (polyhydramnios), which can cause further complications. In severe cases, TTTS can even be fatal for one or both fetuses. To detect TTTS, ultrasound examinations are typically performed between 16 and 24 weeks of pregnancy, while after 24 weeks, the focus shifts to detecting fetal growth restriction.

Multiple Pregnancies: Incidence, Types, and Complications

Multiple pregnancies, such as twins and triplets, have different incidences. Twins occur in 1 out of 105 pregnancies, while triplets occur in 1 out of 10,000 pregnancies. Twins can be either dizygotic or monozygotic, with the former being more common at 80%. Monoamniotic monozygotic twins have higher risks of spontaneous miscarriage, perinatal mortality rate, malformations, intrauterine growth restriction, and prematurity. Twin-to-twin transfusions may occur, which require laser ablation of interconnecting vessels.

Dizygotic twins are becoming more common due to infertility treatment, and predisposing factors include previous twins, family history, increasing maternal age, multigravida, induced ovulation, in-vitro fertilization, and race, particularly Afro-Caribbean. Antenatal complications may arise, such as polyhydramnios, pregnancy-induced hypertension, and anemia, while fetal complications include perinatal mortality, prematurity, light-for-date babies, and malformations.

During labor, complications may occur, such as postpartum hemorrhage, malpresentation, cord prolapse, and entanglement. Management includes rest, ultrasound for diagnosis and monthly checks, additional iron and folate, more antenatal care, and precautions during labor, such as having two obstetricians present. Most twins deliver by 38 weeks, and if longer, most twins are induced at 38-40 weeks.

The correct answer is that magnesium sulphate treatment should continue for 24 hours after delivery or the last seizure. This treatment is used to prevent and treat seizures in mothers with eclampsia. In this case, the patient is showing signs of eclampsia due to high protein levels in her urine, pregnancy-induced hypertension, and seizures. Therefore, she needs to be admitted and continue magnesium treatment for 24 hours after delivery or the last seizure. Magnesium helps prevent seizures by relaxing smooth muscle tissues and slowing uterine contractions. Labetalol is not the correct answer as it is used for long-term treatment of hypertension, which may not be necessary for this patient after delivery. Nifedipine with hydralazine may be more suitable for her hypertension as she is asthmatic. Magnesium sulphate treatment for 12 or 48 hours after delivery or the last seizure is not recommended according to guidelines, which suggest 24 hours is the appropriate duration.

Understanding Eclampsia and its Treatment

Eclampsia is a condition that occurs when seizures develop in association with pre-eclampsia, a pregnancy-induced hypertension that is characterized by proteinuria and occurs after 20 weeks of gestation. To prevent seizures in patients with severe pre-eclampsia and treat seizures once they develop, magnesium sulphate is commonly used. However, it is important to note that this medication should only be given once a decision to deliver has been made. In cases of eclampsia, an IV bolus of 4g over 5-10 minutes should be given, followed by an infusion of 1g/hour. During treatment, it is crucial to monitor urine output, reflexes, respiratory rate, and oxygen saturations. Respiratory depression can occur, and calcium gluconate is the first-line treatment for magnesium sulphate-induced respiratory depression. Treatment should continue for 24 hours after the last seizure or delivery, as around 40% of seizures occur post-partum. Additionally, fluid restriction is necessary to avoid the potentially serious consequences of fluid overload.

In summary, understanding the development of eclampsia and its treatment is crucial in managing this potentially life-threatening condition. Magnesium sulphate is the primary medication used to prevent and treat seizures, but it should only be given once a decision to deliver has been made. Monitoring vital signs and urine output is essential during treatment, and calcium gluconate should be readily available in case of respiratory depression. Finally, fluid restriction is necessary to avoid complications associated with fluid overload.

The initial investigation for preterm prelabour rupture of the membranes is a thorough speculum examination to check for the accumulation of amniotic fluid in the posterior vaginal vault. It is recommended to avoid bimanual examination to minimize the risk of infection. While cardiotocography can be used to assess foetal wellbeing, it is not the preferred first-line investigation. Foetal blood sampling is not the recommended initial investigation due to the potential risks of infection and miscarriage.

Preterm prelabour rupture of the membranes (PPROM) is a condition that occurs in approximately 2% of pregnancies, but it is responsible for around 40% of preterm deliveries. This condition can lead to various complications, including prematurity, infection, and pulmonary hypoplasia in the fetus, as well as chorioamnionitis in the mother. To confirm PPROM, a sterile speculum examination should be performed to check for pooling of amniotic fluid in the posterior vaginal vault. However, digital examination should be avoided due to the risk of infection. If pooling of fluid is not observed, testing the fluid for placental alpha microglobulin-1 protein (PAMG-1) or insulin-like growth factor binding protein-1 is recommended. Ultrasound may also be useful to show oligohydramnios.

The management of PPROM involves admission and regular observations to ensure that chorioamnionitis is not developing. Oral erythromycin should be given for ten days, and antenatal corticosteroids should be administered to reduce the risk of respiratory distress syndrome. Delivery should be considered at 34 weeks of gestation, but there is a trade-off between an increased risk of maternal chorioamnionitis and a decreased risk of respiratory distress syndrome as the pregnancy progresses. PPROM is a serious condition that requires prompt diagnosis and management to minimize the risk of complications for both the mother and the fetus.

Management of Nausea and Vomiting in Pregnancy: Medications and Considerations

Nausea and vomiting in pregnancy are common and can range from mild to severe. Conservative measures such as dietary changes and ginger can be effective for mild symptoms, but oral anti-emetics are recommended for more severe cases. First-line medications include promethazine, cyclizine, and phenothiazines. If these fail, second-line medications such as ondansetron and metoclopramide may be prescribed. Severe cases may require hospital admission, parenteral anti-emetics, and fluid resuscitation. Thiamine is given to all women admitted with severe vomiting. Steroid treatments such as hydrocortisone should be reserved for specialist use. It is important to monitor for side-effects and consider referral to secondary care if necessary.

Pregnant women who have a history of VTE should receive LMWH throughout their pregnancy and up to 6 weeks after giving birth to prevent clotting. Warfarin is not recommended during pregnancy due to its teratogenic effects, and LMWH is preferred due to its lower side effect profile and reduced need for monitoring.

Venous Thromboembolism in Pregnancy: Risk Assessment and Prophylactic Measures

Pregnancy increases the risk of developing venous thromboembolism (VTE), a condition that can be life-threatening for both the mother and the fetus. To prevent VTE, it is important to assess a woman’s individual risk during pregnancy and initiate appropriate prophylactic measures. This risk assessment should be done at the first antenatal booking and on any subsequent hospital admission.

Women with a previous history of VTE are automatically considered high risk and require low molecular weight heparin throughout the antenatal period, as well as input from experts. Women at intermediate risk due to hospitalization, surgery, co-morbidities, or thrombophilia should also be considered for antenatal prophylactic low molecular weight heparin.

The risk assessment at booking should include factors that increase the likelihood of developing VTE, such as age over 35, body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low-risk thrombophilia, multiple pregnancy, and IVF pregnancy.

If a woman has four or more risk factors, immediate treatment with low molecular weight heparin should be initiated and continued until six weeks postnatal. If a woman has three risk factors, low molecular weight heparin should be initiated from 28 weeks and continued until six weeks postnatal.

If a diagnosis of deep vein thrombosis (DVT) is made shortly before delivery, anticoagulation treatment should be continued for at least three months, as in other patients with provoked DVTs. Low molecular weight heparin is the treatment of choice for VTE prophylaxis in pregnancy, while direct oral anticoagulants (DOACs) and warfarin should be avoided.

In summary, a thorough risk assessment and appropriate prophylactic measures can help prevent VTE in pregnancy, which is crucial for the health and safety of both the mother and the fetus.

Conduct a blood test to measure the levels of beta-human chorionic gonadotropin (hCG) in the serum, and then repeat the test after 120 hours.

Bleeding in the First Trimester: Understanding the Causes and Management

Bleeding in the first trimester of pregnancy is a common concern for many women. It can be caused by various factors, including miscarriage, ectopic pregnancy, implantation bleeding, cervical ectropion, vaginitis, trauma, and polyps. However, the most important cause to rule out is ectopic pregnancy, as it can be life-threatening if left untreated.

To manage early bleeding, the National Institute for Health and Care Excellence (NICE) released guidelines in 2019. If a woman has a positive pregnancy test and experiences pain, abdominal tenderness, pelvic tenderness, or cervical motion tenderness, she should be referred immediately to an early pregnancy assessment service. If the pregnancy is over six weeks gestation or of uncertain gestation and the woman has bleeding, she should also be referred to an early pregnancy assessment service.

A transvaginal ultrasound scan is the most important investigation to identify the location of the pregnancy and whether there is a fetal pole and heartbeat. If the pregnancy is less than six weeks gestation and the woman has bleeding but no pain or risk factors for ectopic pregnancy, she can be managed expectantly. However, she should be advised to return if bleeding continues or pain develops and to repeat a urine pregnancy test after 7-10 days and to return if it is positive. A negative pregnancy test means that the pregnancy has miscarried.

In summary, bleeding in the first trimester of pregnancy can be caused by various factors, but ectopic pregnancy is the most important cause to rule out. Early referral to an early pregnancy assessment service and a transvaginal ultrasound scan are crucial in identifying the location of the pregnancy and ensuring appropriate management. Women should also be advised to seek medical attention if they experience any worrying symptoms or if bleeding or pain persists.

Safe Pain Management Options for Breastfeeding Mothers

Breastfeeding mothers who experience pain may require medication to manage their symptoms. However, certain drugs can be harmful to both the mother and the baby. Here are some safe pain management options for breastfeeding mothers:

Ibuprofen: This is the drug of choice for managing pain in breastfeeding mothers. Although it is contraindicated in pregnancy, its transfer into breast milk is very low.

Codeine: This opioid analgesic can be used during pregnancy, but it should be avoided as the mother approaches delivery due to the risk of respiratory depression in the infant. It should also be avoided when breastfeeding, as it can cause symptoms of overdose in the baby.

Aspirin: While aspirin is used during pregnancy for prophylaxis, its use as an analgesic should be avoided during breastfeeding as it can cause Reye’s syndrome or impair neonatal platelet function.

Indometacin: This NSAID can be used for analgesia in breastfeeding, as the concentration that transfers into breast milk is relatively low.

Tramadol: Although only small amounts of this opioid analgesic are present in breast milk, the manufacturers advise avoidance due to the risk of respiratory depression in the baby.

It is important to consult with a healthcare provider before taking any medication while breastfeeding. Additionally, mothers should be aware of any contraindications and potential side effects of the medication they are taking.

Management of Retained Placenta in Obstetrics

Retained placenta is a common complication in obstetrics that requires prompt management to prevent severe bleeding and other complications. Here are the steps involved in managing retained placenta:

Observation and Intramuscular Syntocinon® and Breastfeeding
After delivery, the clock starts, and the midwife should observe the patient for 30 minutes. If there is no bleeding, the patient can be observed for another 30 minutes while establishing IV access and crossmatching blood. During this time, im Syntocinon® and breastfeeding can be used to stimulate spontaneous expulsion.

Full Obstetric Emergency Team Resuscitation
If the patient is bleeding heavily, retained placenta is classified as an obstetric emergency, and resuscitation is necessary. IV access should be confirmed, and blood should be grouped and crossmatched.

Commence a Syntocinon® Infusion
To encourage separation of the placenta from the uterus, Syntocinon® is given im into the quadriceps, rather than as an infusion.

Observation with IM Syntocinon® and Breastfeeding
The patient can be observed for another 60 minutes with im Syntocinon® and breastfeeding to encourage spontaneous expulsion.

Surgical Removal under General Anaesthesia
If after an hour, the placenta is still retained, the patient should be taken to theatre for surgical removal under general anaesthesia.